Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:103-109

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, W.
Right arrow Articles by Michel, J.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, W.
Right arrow Articles by Michel, J.-B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Remodeling
Right arrow ACE/Angiotension receptors
Right arrow Smooth muscle proliferation and differentiation
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:103.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Molecular Plasticity of Vascular Wall During NG-Nitro-L-Arginine Methyl Ester–Induced Hypertension

Modulation of Proinflammatory Signals

Walter Gonzalez; Vincent Fontaine; Maria E. Pueyo; Nathalie Laquay; David Messika-Zeitoun; Monique Philippe; Jean-François Arnal; Marie-Paule Jacob; Jean-Baptiste Michel

From INSERM U460, CHU X. Bichat, Paris France, and INSERM U397 (J.-F.A.), CHU Rangueil, Toulouse, France.

Correspondence to Jean-Baptiste Michel, MD, PhD, INSERM U460, Cardiovascular Remodeling, Faculté de Médecine Xavier Bichat, 16, rue H. Huchard, 75018 Paris, France. E-mail u460{at}bichat.inserm.fr

Abstract—It has previously been reported that hypertension induced by the chronic blockade of NO production is characterized by a proinflammatory phenotype of the arterial wall associated with a periarterial accumulation of inflammatory cells. In the present study, the cellular and molecular mechanisms involved in the luminal and perivascular accumulation of inflammatory cells were evaluated in the aortas of NG-nitro-L-arginine methyl ester (L-NAME)–treated rats. Because the medial layer remains intact, putative markers of the resistance of the vascular wall to cell migration and to oxidative stress were also explored. For this purpose, monocyte adhesion, cytokine expression, superoxide anion production, and nuclear factor-{kappa}B (NF-{kappa}B) activation were assessed in the aortas of L-NAME–treated rats. Expressions of tissue inhibitor of metalloproteinases-1 (TIMP-1) and heme oxygenase-1 (HO-1) in the aortic wall were also studied as possible markers of such resistance. Chronic blockade of NO production increased ex vivo monocyte adhesion to the endothelium, increased the production of superoxide anions, and activated the NF-{kappa}B system. In concert with this modification of the redox state of the vascular wall in L-NAME–treated rats, the expression of proinflammatory cytokines interleukin-6, monocyte chemoattractant protein-1, and macrophage colony–stimulating factor was increased. In parallel, expressions of both TIMP-1 and HO-1 were increased. All these changes were prevented by treatment with an angiotensin-converting enzyme inhibitor (Zofenopril). Hypertension associated with a proinflammatory phenotype of the vascular wall induced by blockade of NO production could be due to an increase in oxidative stress, which, in turn, activates the NF-{kappa}B system and increases gene expression. In parallel, the arterial wall overexpresses factors such as TIMP-1 and HO-1, which could participate in the resistance to cell migration and oxidative stress.


Key Words: Keys words: anions • angiotensin-converting enzyme inhibitors • cytokines • matrix metalloproteinases • remodeling




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman
Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-B. Michel, O. Thaunat, X. Houard, O. Meilhac, G. Caligiuri, and A. Nicoletti
Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1259 - 1268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Alam and J. L. Cook
How Many Transcription Factors Does It Take to Turn On the Heme Oxygenase-1 Gene?
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O. Fondard, D. Detaint, B. Iung, C. Choqueux, H. Adle-Biassette, M. Jarraya, U. Hvass, J.-P. Couetil, D. Henin, J.-B. Michel, et al.
Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors
Eur. Heart J., July 1, 2005; 26(13): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Sanz-Rosa, M. P. Oubina, E. Cediel, N. de las Heras, O. Vegazo, J. Jimenez, V. Lahera, and V. Cachofeiro
Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-{kappa}B/I{kappa}B system
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H111 - H115.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Dupuis, F. Soubrier, I. Brocheriou, S. Raoux, M. Haloui, L. Louedec, J.-B. Michel, and S. Nadaud
Profiling of Aortic Smooth Muscle Cell Gene Expression in Response to Chronic Inhibition of Nitric Oxide Synthase in Rats
Circulation, August 17, 2004; 110(7): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Mazighi, A. Pelle, W. Gonzalez, E. M. Mtairag, M. Philippe, D. Henin, J.-B. Michel, and L. J. Feldman
IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H866 - H871.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
J. L. Unthank, K. M. Sheridan, and M. C. Dalsing
Collateral Growth in the Peripheral Circulation: A Review
Vascular and Endovascular Surgery, July 1, 2004; 38(4): 291 - 313.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
M. G Ferrini, H. H Davila, E. G.A Valente, N. F Gonzalez-Cadavid, and J. Rajfer
Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media
Cardiovasc Res, March 1, 2004; 61(4): 796 - 805.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Boixel, V. Fontaine, J.-B. Michel, M.-P. Jacob, and S. Hatem
Matrix metalloproteinases in atrial fibrillation: Reply
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 152 - 153.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. A. Lemarie, B. Esposito, A. Tedgui, and S. Lehoux
Pressure-Induced Vascular Activation of Nuclear Factor-{kappa}B: Role in Cell Survival
Circ. Res., August 8, 2003; 93(3): 207 - 212.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. Gaertner, D. Lepailleur-Enouf, W. Gonzalez, A. Nicoletti, C. Mandet, M. Philippe, J.-J. Mercadier, and J.-B. Michel
Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure
Eur J Heart Fail, August 1, 2003; 5(4): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-C. Bouton, B. Richard, P. Rossignol, M. Philippe, M.-C. Guillin, J.-B. Michel, and M. Jandrot-Perrus
The Serpin Protease-Nexin 1 Is Present in Rat Aortic Smooth Muscle Cells and Is Upregulated in L-NAME Hypertensive Rats
Arterioscler Thromb Vasc Biol, January 13, 2003; 23(1): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. S. Sarang, T. Yoshida, R. Cadet, A. S. Valeras, R. V. Jensen, and S. R. Gullans
Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays
Physiol Genomics, October 29, 2002; 11(2): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M.A.C. Martens, B. Demeilliers, D. Girardot, C. Daigle, H. H. Dao, D. deBlois, and P. Moreau
Vessel-Specific Stimulation of Protein Synthesis by Nitric Oxide Synthase Inhibition: Role of Extracellular Signal-Regulated Kinases 1/2
Hypertension, January 1, 2002; 39(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-B. Michel
Contrasting Outcomes of Atheroma Evolution: Intimal Accumulation Versus Medial Destruction
Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1389 - 1392.
[Full Text] [PDF]


Home page
CirculationHome page
L. J. Feldman, M. Mazighi, A. Scheuble, J.-F. Deux, E. De Benedetti, C. Badier-Commander, E. Brambilla, D. Henin, P. G. Steg, and M.-P. Jacob
Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic Rabbit
Circulation, June 26, 2001; 103(25): 3117 - 3122.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Tedgui and Z. Mallat
Anti-Inflammatory Mechanisms in the Vascular Wall
Circ. Res., May 11, 2001; 88(9): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell, and W. Ricart
Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1154 - 1159.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
E. Mostafa Mtairag, S. Chollet-Martin, M. Oudghiri, N. Laquay, M.-P. Jacob, J.-B. Michel, and L. J. Feldman
Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion
Cardiovasc Res, March 1, 2001; 49(4): 882 - 890.
[Abstract] [Full Text] [PDF]